Whether it's the Ebola virus or Sarin and Ricin, a key to responding to chemical or biological attacks is having effective antidotes at the ready. To accelerate the development of new therapies, Wake Forest Baptist Medical Center's Institute for Regenerative Medicine is leading a unique $24 million federally funded project to develop a "body on a chip" that will be used to develop these countermeasures.
Calgary Scientific today shared that its ResolutionMD diagnostic medical imaging software was formally evaluated by clinicians during a structured research study at the Mayo Clinic in Arizona and determined to be significantly faster than the two PACS and desktop image-viewing systems currently in use at the facility.
New research from Western University is leading to a better understanding of what happens during heart failure; knowledge that could lead to better therapeutics or a more accurate predictor of risk. The research--led by Robarts Research Institute scientists Robert Gros, Ph.D., and Marco Prado, Ph.D...
The research led by Robarts Research Institute scientists Robert Gros, PhD, and Marco Prado, PhD, along with graduate student Ashbeel Roy found the heart is regulated not only by nervous systems but also by heart cells sending messages to each other through the release of the neurotransmitter acetylcholine (ACh).
Researchers at the Technische Universitaet Muenchen (TUM) are showing the way toward low-cost, industrial-scale manufacturing of a new family of electronic devices. A leading example is a gas sensor that could be integrated into food packaging to gauge freshness, or into compact wireless air-quality monitors.
Carbon nanotube-based gas sensors created at TUM offer a unique combination of characteristics that can't be matched by any of the alternative technologies. They rapidly detect and continuously respond to extremely small changes in the concentrations of gases including ammonia, carbon dioxide, and nitrogen oxide.
OLED technology is used today in screens for many smartphones and some televisions. The new ultra-stretchable OLED material developed at UCLA could lead to foldable and expandable screens for new classes of smartphones and other personal electronic devices; new minimally invasive medical tools; and many other applications.
Retinal (or fundus) photography is an essential part of any ophthalmology practice. Commercial fundus cameras can cost tens to hundreds of thousands of dollars, making the technology out of reach for smaller ophthalmic practices and to physicians in third-world countries.
Food and Drug Administration officials say they will begin regulating a new wave of applications and gadgets that work with smartphones to take medical readings and help users monitor their health. With the rise of the iPhone, Android and other mobile devices has come a flood of applications designed to help people stay healthy.
AirSonea, the world’s first smartphone-enabled device for monitoring wheeze, was unveiled Tuesday in Melbourne, Australia, by the United States management team of iSonea Ltd. Expected in the United States in 2014, the discreet-in-size and easy-to-use AirSonea is a handheld device that turns a person’s smartphone into a portable wheeze monitor.
Researchers have made an exciting breakthrough – developing a first-of-its-kind imaging tool to examine myelin damage in multiple sclerosis (MS). An extremely difficult disease to diagnose, the tool will help physicians diagnose patients earlier, monitor the disease’s progression, and evaluate therapy efficacy.
Investorideas.com, an investor research portal specializing in investing ideas in leading sectors including biotech and medical technology stocks, issues an exclusive Q&A with Jim Joyce, Chairman and CEO of Aethlon Medical, Inc. (OTCQB: AEMD). Mr. Joyce discusses the recent launch of its new Exosome Sciences, Inc. (ESI) and what that potentially represents to Aethlon and its shareholders.
Seven out of 9 hospitals and healthcare providers surveyed "strongly" agreed that medical device makers need to step up their cybersecurity and privacy practices, according to a study conducted by the Deloitte Center for Health Solutions.
In the field of medical technology, wireless devices are seeing some of the most broad-reaching growth. This is due mostly in part to the wide range of applications that wireless medicine encompasses. Mobi Health News reports that the top ten areas wireless medicine has directly benefited include: Alzheimer’s, asthma, breast cancer, COPD, depression, diabetes, heart failure, hypertension, obesity, and sleep disorders.
I can be a kid at heart. And when I say that, I state it with an almost literal meaning. I still enjoy toys. Now, I’m not the 40-year-old virgin character from the movie of the same name, but I can’t admit to not still tinkering with Lego bricks and finding enjoyment from it.
American Academy of Family Physicians Scientific Assembly—Innovative solutions that help improve patient outcomes and practice workflow will be on display at the American Academy of Family Physicians (AAFP) Scientific Assembly this week in San Diego.
Given Imaging has announced that Japan's Pharmaceuticals and Medical Devices Agency has granted approval for the PillCam SB 3 system. The innovative technology in this third-generation system will provide physicians throughout Japan with the most advanced PillCam capsule endoscopy technology to detect and monitor small bowel diseases, such as Crohn's disease.
The medical device and diagnostics market is set to grow at 4.5 percent per year (CAGR) between 2012 and 2018, totalling $455 billion in 2018, according to the newly-released EvaluateMedTech World Preview 2013, Outlook to 2018: The Future of Medtech report from market intelligence firm Evaluate Ltd.
Mayo Clinic researchers have shown that a specific protein pair may be a successful prognostic biomarker for identifying smoking-related lung cancers. The protein — ASCL1 — is associated with increased expression of the RET oncogene, a particular cancer-causing gene called RET.
Researchers at MIT have developed a microfluidic device that mimics the flow of cancer cells through a system of blood vessels. Using high-resolution time-lapse imaging, the researchers captured the moments as a cancer cell squeezes its way through a blood vessel wall into the surrounding extracellular matrix.
A new, non-invasive imaging technique, magnetic resonance elastography, can now help physicians accurately detect fibrosis in children with chronic liver disease. A new study shows that MRE detects such chronic diseases as non-alcoholic fatty liver disease, which is increasingly common in children and teens, affecting an estimated 13 percent of adolescents.
Florida Hospital Collaborates with VTT of Finland to Explore Research for Early Detection of Alzheimer’s DiseaseSeptember 19, 2013 11:36 am | by Technical Research Centre of Finland (VTT) | News | Comments
In an effort to better understand the development of Alzheimer’s disease, Florida Hospital Neuroscience Institute and VTT Technical Research Centre of Finland are collaborating to identify the biomarker assay that may predict early onsets of the disease.
It happens too often: A doctor isn't sure what's causing someone's feverish illness but prescribes antibiotics just in case, drugs that don't work if a virus is the real culprit. Now Duke University researchers are developing a blood test to more easily tell when a respiratory illness is due to a virus and not a bacterial infection, hoping to cut the dangerous overuse of antibiotics and speed the right diagnosis.
A handheld device for diagnosing the early signs of osteoporosis could be available for clinical use within five years. The technology is currently being refined and tested at the University of Southampton with support from the Engineering and Physical Sciences Research Council (EPSRC).
Imec and Panasonic are jointly developing a fully integrated sample-to-answer device to perform molecular diagnostic tests. Recently, they’ve created prototype of the device. The chip is about half the size of a credit card that performs fast, simple and sensitive detection of genetic markers, specifically single nucleotide polymorphisms (SNPs).